Important milestones achieved in Clinical Studies of Stent & Balloon Catheter 2007.06.15

 
Lee's Pharmaceutical Holdings Limited (GEM) Stock: 8221; Website: www.leespharm.com) today announced that the Group has successfully completed the enrollment of patients for a clinical trial on Horus®s (Coronary Stent with delivery system), following the completion of clinical study on evaluating the effects of Challenger® PTCA Balloon Catheter for patients with coronary heart disease.
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD